Poster Poster Program Clinical Trials Specialty Program

Radiopharmaceutical Trial Program Ramp-up : The University of Miami Experience Described Using the People, Processes, Technology Framework for Organizational Change

Abstract
Purpose

Describe highlights of organizational changes that allowed for the ramp-up of the radiopharmaceutical trials program at the University of Miami Health System (UHealth)

Methods

Organizational change to facilitate the ramp-up of radiopharmaceutical trials at UHealth were undertaken, and presented under the People, Processes, Technology (PPT) Framework.

Results

Implementation of changes under PPT Framework resulted in the alignment of resources which facilitated the ramp-up of the radiopharmaceutical trials program at UHealth. Highlights of "People" changes include aligning Principal Investigators, Committees, and key personnel; "Processes" changes include developing charters/procedures, training, clinical workflows, and quality management programs; "Technology" changes include developing the physical infrastructure, equipment purchases, and instrument qualification.

Conclusion

The radiopharmaceutical trials program at UHealth is currently thriving as a direct result of strategic and organizational change. Elements of the PPT Framework implemented at UHealth may be provide useful examples for other organizations seeking to initiate or expand radiopharmaceutical trials.

People

Related

Similar sessions

Poster GPD-T-1080 Poster Program Exhibit Hall | Poster Lounge
Jul 19 · 15:15
A Medical Physics–Driven Clinical Trial of Temporally Modulated Pulsed Radiotherapy (NRG-CC017)

To design and validate reliable treatment planning and delivery verification methods for TMPRT in the phase III NRG CC-017 trial, which compares TMPRT to standard radiotherapy in adults with newly diagnosed MGMT-unmethylated glio...

Christian Velten, PhD
Clinical Trials Specialty Program 0 people interested
Poster GPD-T-40 Poster Program Exhibit Hall | Poster Lounge
Jul 19 · 15:15
Deep Learning-Based LS-SCLC Patient Selection for the New First-Line Treatment Using High-Dose Hyperfractionated SIB Radiotherapy

To develop risk-stratification and prognosis-prediction models for limited-stage small cell lung cancer (LS-SCLC) patients, suggesting potential candidates that may benefit from the new treatment protocol using high-dose hyperfra...

Yibao Zhang
Clinical Trials Specialty Program 0 people interested